# Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.

> **NCT01397994** · PHASE4 · UNKNOWN · sponsor: **Ferozsons Laboratories Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Stable Angina

## Interventions

- **DRUG:** Nicorandil
- **DRUG:** Atenolol

## Key facts

- **NCT ID:** NCT01397994
- **Lead sponsor:** Ferozsons Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01397994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01397994, "Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01397994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*